The coronavirus disease 2019 (COVID-19) can disrupt various brain functions. Over a one-year period, we aimed to assess brain activity and cognitive function in 53 COVID-19 patients and 30 individuals without COVID-19 (or asymptomatic). The Montreal Cognitive Assessment, Trail Making Test Parts A and B (TMT-A and B), and Digit Span Test were used to assess cognitive function. Cognitive variables and electroencephalography (EEG) data (activity, mobility, and complexity) were compared between the groups at rest and during cognitive demand (F3-F7, Fz-F3, Fz-F4, and F4-F8). There was a reduction in F3-F7 activity during the TMT-B in the COVID-19 group at 6-12 months compared to the controls (p = 0.01) at baseline (p = 0.03), a reduction in signal complexity at F3-F7 at rest in the COVID-19 group at baseline and 6-12 months compared to the controls (p < 0.001), and a reduction in Fz-F4 activity at rest from 6-12 months in the post-COVID group compared to baseline (p = 0.02) and 3-6 months (p = 0.04). At 6-12 months, there was a time increase in TMT-A in the COVID-19 group compared to that in the controls (p = 0.04). Some correlations were found between EEG data and cognitive test in both groups. In conclusion, there was a reduction in brain activity at rest in the Fz-F4 areas and during high cognitive demands in the F3-F7 areas. A reduction in signal complexity in F3-F7 at rest was found in the COVID-19 group at 6-12 months after acute infection. Furthermore, individuals with COVID-19 experience long-term changes in cognitive function.
LiQGuanXWuP, et al.Early transmission dynamicsinWuhan,China,ofnovelcoronavirus- infected pneumonia. N Engl J Med. 2020;382(13):1199–1207. doi:10.1056/NEJMoa2001316
2.
HuangCWangYLiX, et al.Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. https://doi.org/10.1016/S0140-6736(20)30183-5
3.
MaoLJinHWangM, et al.Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):683–690. https://.doi:10.1001/jamaneurol.2020.1127
4.
CrookHRazaSNowellJYoungMEdisonP. Long COVID - mechanisms, risk factors, and management. Br Med J.2021;37(4):n1648. http://dx.doi.org/10.1136/bmj.n1648
5.
Romero-SánchezCMDíaz-MarotoIFernández-DíazE, et al.Neurologic manifestations in hospitalized patients with COVID-19: the ALBACOVID registry. Neurology. 2020;95(8):e1060–e1070. doi:10.1212/WNL.0000000000009937
6.
ErmisURustMIBungenbergJ, et al.Neurological symptoms in COVID-19: a cross-sectional monocentric study of hospitalized patients. Neurol Res Pract. 2021;3(1):17. https://doi.org/10.1186/s42466-021-00116-1
7.
XiaHLazartiguesE. Angiotensin-converting enzyme 2 in the brain: properties and future directions. J Neurochem. 2008;107 (6):1482–1494. doi:10.1111/j.1471-4159.2008.05723.x
8.
JakhmolaSIndariOChatterjeeSJhaHC. SARS-CoV-2, an underestimated pathogen of the nervous system. SN Compr Clin Med. 2020;2:2137–2146. doi:10.1007/s42399-020-00522-7
9.
ChiappelliF. Towards neuro-CoViD-19. Bioinformation. 2020;16(4):288–292. doi:10.6026/97320630016288
10.
ZhouZKangHLiSZhaoX. Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms. J Neurol. 2020;267:2179–2184. doi:10.1007/s00415-020-09929-7
11.
BaigAMKhaleeqAAliUSyedaH. Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci. 2020;11(7):995–998. doi:10.1021/acschemneuro.0c00122
12.
VerdecchiaPCavalliniCSpanevelloAAngeliF. The pivotal link between ACE2 deficiency and SARS-CoV-2 infection. Eur J Intern Med. 2020;76:14–20. doi:10.1016/j.ejim.2020.04.037
13.
EdisonP. Brain connectivity and COVID-19. Brain Connect. 2021;11(4):251–252. doi:10.1089/brain.2021.29022.ped
14.
EdisonP. Brain connectivity and neurological sequalae in COVID-19. Brain Connect. 2021;11(5):331–332. doi:10.1089/brain.2021.29023.ped
15.
FuZTuYCalhounVD,et al.Dynamic functional network connectivity associated with post-traumatic stress symptoms in COVID-19 survivors. Neurobiol Stress. 2021 Nov;15:100377. doi:10.1016/j.ynstr.2021.100377
16.
DouaudGLeeSAlfaro-AlmagroF, et al.Brain imaging before and after COVID-19. UK Biobank MedRxiv. 2021;604:1–55. doi:10.1101/2021.06.11.21258690
17.
HampshireATrenderWChamberlainSR, et al.Cognitive deficits in people who have recovered from COVID-19. EClinicalmedicine. 2021 Jul 23;39:101044. doi:10.1016/j.eclinm.2021.101044
18.
LuYLiXGengD, et al.Cerebral micro-structural changes in COVID-19 patients - an MRI-based 3 month follow-up study. EClinicalmedicine. 2020;25:100484. https://doi.org/10.1016/j.eclinm.2020.100484
19.
DouaudGLeeSAlfaro-AlmagroF, et al.SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. 2022;604(7907):697–707. doi:10.1038/s41586-022-04569-5. Epub ahead of print. PMID: 35255491.
20.
BurleBSpieserLRogerCCasiniLHasbroucqTVidalF. Spatial and temporal resolutions of EEG: is it really black and white? A scalp current density view. Int J Psychophysiol. 2015;97(3):210–220. doi:10.1016/j.ijpsycho.2015.05.004]
21.
GalanopoulouASFerastraoaruVCorreaDJ, et al.EEG Findings in acutely ill patients investigated for SARS-CoV-2/COVID-19: a small case series preliminary report. Epilepsia Open. 2020;5(2):314–324. doi:10.1002/epi4.12399
22.
FriedmanNFeketeTGalKShrikiO. EEG-based prediction of cognitive load in intelligence tests. Front Hum Neurosci. 2019;13:191. doi:10.3389/fnhum.2019.00191
23.
MehmoodRMLeeHJ. Towards emotion recognition of EEG brain signals using Hjorth parameters and SVM. Adv Sci Technol Lett Biosci Med Res. 2015;91:24–27.
24.
CecchinTRantaRKoesslerLCasparyOVespignaniHMaillardL. Seizure lateralization in scalp EEG using Hjorth parameters. Clin Neurophysiol. 2010;121(3):290–300.
25.
PezardLNandrinoJRenaultB, et al.Depression as a dynamical disease. Biol Psychiatry. 1996;39(12):991–999.
26.
SafiMSSafiSMM. Early detection of Alzheimer’s disease from EEG signals using Hjorth parameters. Biomed Signal Process Control.2021;65(11):102338. https://doi.org/10.1016/j.bspc.2020.102338
27.
HjorthB. EEG Analysis based on time domain properties. Electroencephalogr Clin Neurophysiol. 1970;29(3):306–310. doi:10.1016/0013-4694(70)90143-4
28.
HjorthB. Physical aspects of EEG data as a basis for topographic mapping. In: Duffy f H topographic mapping of brain electrical activity. Butterworths; 1986:175–193.
29.
HjorthB. Time domain descriptors quantify EEG changes related to hypothyroidism. Electroencephalogr Clin Neurophysiol. 1975;38(2):208–216.
30.
LiYXiaoSLiYLiYYangB. 2020. Classification of Mild Cognitive Impairment from multi-domain features of resting-state EEG. Engineering in Medicine & Biology Society (EMBC) 42nd Annual International Conference of the IEEE, pp. 256-259. doi:10.1109/EMBC44109.2020.9176053.
31.
GrahamELClarkJROrbanZS, et al.Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized COVID-19 “long haulers”. Ann Clin Transl Neurol. 2021;8(5):1073–1085. https://.doi:10.1002/acn3.51350
32.
AgostaFVabanesiMCanuE, et al.Prospective EEG evaluation in patients with recent COVID-19 and cognitive disturbances. Eur J Neurol. 2021;28(suppl 1):250.
33.
ZhaiWLuoZZhengY, et al.Moderate vs. mild cases of overseas-imported COVID-19 in Beijing: a retrospective cohort study. Sci Rep. 2021;11:6483. doi:10.1038/s41598-021-85869-0
34.
CampbellWW. De Jonǵs The Neurologic Examination. Lippincott, Williams & Wilkins. 6th ed. 2005.
35.
BotegaNJPereiraWABBioMRGarcia JúniorCZomignaniMA. Psychiatric morbidity among medical in-patients: a standardized assessment (GHQ-12 and CIS-R) using ‘lay’ interviewers in a Brazilian hospital. Soc Psychiatry Psychiatr Epidemiol. 1995;30(3):127–131. doi:10.1007/BF00802041
36.
LimaDHQueirozAPDe SalvoGYoneyamaSMObergTDLimaNM. Brazilian version of the Nottingham sensory assessment: validity, agreement and reliability. Rev Bras Fisioter. 2010 Mar-Apr;14(2):166–174. doi:10.1590/S1413-35552010005000006
37.
TuranZTopalogluMOzyemisci TaskiranO. Medical research council-sumscore: a tool for evaluating muscle weakness in patients with post-intensive care syndrome. Crit Care. 2020;24(1):562. DOI:10.1186/s13054-020-03282-x
38.
MachadoFVCMeysRDelbressineJM, et al.Construct validity of the post-COVID-19 functional Status scale in adult subjects with COVID-19. Health Qual Life Outcomes. 2021;19(1):40. https://doi.org/10.1186/s12955-021-01691-2
39.
NasreddineZSPhillipsNABédirianV, et al.The Montreal cognitive assessmente, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695–699. doi:10.1111/j.1532-5415.2005.53221.x
40.
GaudinoEAGeislerMWSquiresNK. Construct validity in the trail making test: what makes part B harder?J Clin Exp Neuropsychol. 1995;17(4):529–535. doi:10.1080/01688639508405143
41.
ReynoldsCR. Forward and backward memory span should not be combined for clinical analysis. Arch Clin Neuropsychol. 1997;12(1):29–40.
42.
JasperHH. Localized analyses of human brain function by the electroencephalogram. J Nerv Ment Disord. 1936;84:679–683.
Sweeney-ReedCMNasutoSJVieiraMFAndradeAO. Empirical mode decomposition and its extensions applied to EEG analysis: a review. Advances in Data Science and Adaptive Analysis. 2018;1(2):1840001. https://doi.org/10.1142/S2424922X18400016
45.
VellieuxGSonnevilleRVledoutsSJaquetPRouvel-TallecAd’OrthoMP. COVID-19-Associated neurological manifestations: an emerging electroencephalographic literature. Feb. Front Physiol. 2020;11:622466. doi:10.3389/fphys.2020.622466
46.
FullardJFLeeHCVoloudakisG, et al.Single-nucleus transcriptome analysis of human brain immune response in patients with severe COVID-19. Genome Med. 2021 Jul 19;13(1):118. doi:10.1186/s13073-021-00933-8
47.
PatiSTothEChaitanyaG. Quantitative EEG markers to prognosticate critically ill patients with COVID-19: a retrospective cohort study. Clin Neurophysiol. 2020;131(8):1824–1826. doi:10.1016/j.clinph.2020.06.001
48.
Schreiter-GasserUGasserTZieglerP. Quantitative EEG analysis in early onset Alzheimer’s disease: correlations with severity, clinical characteristics, visual EEG and CCT. Electroencephalogr Clin Neurophysiol. 1994;90(4):267–272. doi:10.1016/0013-4694(94)90144-9
49.
JeongJ. EEG Dynamics in patients with Alzheimer disease. Clin Neurophysiol. 2004;115(7):1490–1505. doi:10.1016/j.clinph.2004.01.001
50.
StamCJvan der MadeYPijnenburgYAScheltensP. EEG Synchronization in mild cognitive impairment and Alzheimer’s disease. Acta Neurol Scand. 2003;108(2):90–96. doi:10.1034/j.1600-0404.2003.02067.x
51.
Al-NuaimiAHHJammehESunLIfeachorE. Complexity measures for quantifying changes in electroencephalogram in Alzheimer’s disease. Complexity. 2018;2018:1–12. doi:10.1155/2018/8915079
52.
Ibáñez-MolinaAJLozanoVSorianoMFAznarteJIGómez-ArizaCJBajoMT. EEG Multiscale complexity in schizophrenia during picture naming. Front Physiol. 2018;9:1213. doi:10.3389/fphys.2018.01213
53.
Martin-LoechesMGarcia-TraperoJGilPRubiaFJ. Topography of mobility and complexity parameters of the EEG in Alzheimer’s disease. Biol Psychiatry. 1991 Dec 1;30(11):1111–1121. doi:10.1016/0006-3223(91)90181-k. PMID: 1777528.
54.
FrancisMJNKeranMPChetanRKrupaBN. EEG-Controlled Robot navigation using Hjorth parameters and Welch-PSD. International Journal of Intelligent Engineering and Systems. 2021;14(4):231–240. doi:10.22266/ijies2021.0831.21
55.
YoussefNXiaoSLiuM,et al.Functional brain networks in mild cognitive impairment based on resting electroencephalography signals. Front Comput Neurosci. 2021;15:698386. doi:10.3389/fncom.2021.698386
56.
ChowJCOuyangCSChiangCT,et al.Novel method using Hjorth mobility analysis for diagnosing attention-deficit hyperactivity disorder in girls. Brain Dev. 2019 Apr;41(4):334–340. doi:10.1016/j.braindev.2018.11.006
57.
Mouzé-AmadyMHorwatF. Evaluation of Hjorth parameters in forearm surface EMG analysis during an occupational repetitive task. Electroencephalogr Clin Neurophysiol. 1996 Apr;101(2):181–183. doi:10.1016/0924-980x(96)00316-5
58.
RizalAHadiyosoS. ECG Signal classification using Hjorth descriptor. 2015 International Conference on Automation, Cognitive Science, Optics, Micro Electro-Mechanical System, and Information Technology (ICACOMIT). 2015(2):87–90. doi:10.1109/ICACOMIT.2015.7440181
59.
LiuYLanZKhooHHGLiKHHSourinaOMueller-WittigW. EEG-based Evaluation of mental fatigue using machine learning algorithms. 2018 International Conference on Cyberworlds (CW). 2018:276–279. doi:10.1109/CW.2018.00056
60.
AlvesFOZaninottoALCMiotoECde LuciaMCSScaffM. Evaluation of alternating and sustained attention in a sample of healthy adults with high level of schooling. Psicol Hosp. (São Paulo). 2010;8(2):89–105.
61.
AmievaHLafontSAuriacombeS,et al.Analysis of error types in the trail making test evidences an inhibitory deficit in dementia of the Alzheimer type. J Clin Exp Neuropsychol. 1998;20(2):280–285. doi:10.1076/jcen.20.2.280.1161
62.
MacPhersonSEDella SalaSCoxSRGirardiAIvesonMH. Handbook of frontal lobe assessment. OUP; 2015.
63.
TaquetMGeddesJRHusainMLucianoSHarrisonPJ. 6-month Neurological and psychiatric outcomes in 236379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8:416–427. doi:10.1093/med:psych/9780199669523.001.0001
64.
Al-AlyZXieYBoweB. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021;594(5):259–264. doi:10.1038/s41586-021-03553-9
65.
FigueroaJDBrennanPMTheodoratouE, et al.Distinguishing between direct and indirect consequences of COVID-19. Br Med J.2020;369(7862):m2377. doi:10.1136/bmj.m2377
66.
Del RioCCollinsLFMalaniP. Long-term health consequences of COVID-19. JAMA. 2020;324:1723–1724. doi:10.1001/jama.2020.19719
67.
KnipeDEvansHMarchantAGunnellDJohnA. Mapping population mental health concerns related to COVID-19 and the consequences of physical distancing: a Google trends analysis. Wellcome Open Res. 2020;5(17):82. doi:10.12688/wellcomeopenres.15870.2
68.
MahaseE. COVID-19: mental health consequences of pandemic need urgent research, paper advises. Br Med J.2020;369:m1515. doi:10.1136/bmj.m1515
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
